Bacteriophage therapy and the mutant selection window

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 12, 2008, Pages 4344-4350

  Cairns, Benjamin J ^a,b   Payne, Robert J H ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIOPHAGE; DRUG EFFECT; EMERGENCY TREATMENT; EXPERIMENTAL TEST; MUTANT; NONHUMAN; PRIORITY JOURNAL;

BACTERIA; BACTERIAL INFECTIONS; BACTERIOPHAGES; HUMANS; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MODELS, BIOLOGICAL; MUTATION; SELECTION (GENETICS);

EID: 57049159413     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00574-08     Document Type: Article

References (33)

1. Alisky, J., K. Iczkowski, A. Rapoport, and N. Toitsky. 1998. Bacteriophages show promise as antimicrobial agents. J. Infect. 36:5-15.
2. Cairns, B. J., A. R. Timms, V. A. A. Jansen, I. F. Connerton, and R. J. H. Payne. Quantitative models of in vitro bacteriophage-host dynamics and their application to phage theraphy. PLoS Pathog., in press.
3. Clark, J. R., and J. B. March. 2006. Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Trends Biotechnol. 24:212-218.
4. Dong, Y., X. Zhao, J. Domagala, and K. Drlica. 1999. Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus. Antimicrob. Agents Chemother. 43:1756-1758.
5. Drlica, K., and X. Zhao. 2004. Is 'dosing-to-cure' appropriate in the face of antimicrobial resistance? Rev. Med. Microbiol. 15:73-80.
6. Epstein, B. J., J. G. Gums, and K. Drlica. 2004. The changing face of antibiotic prescribing: the mutant selection window. Ann. Pharmacother. 38:1675-1682.
7. Food and Drug Administration. 2006. Food additives permitted for direct addition to food for human consumption: bacteriophage preparation. Fed. Regist. 71:47729-47732.
8. Hanlon, G. W. 2007. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int. J. Antimicrob. Agents 30:118-128.
9. Hesje, C. K., G. S. Tillotson, and J. M. Blondeau. 2007. MICs, MPCs and PK/PDs: a match (sometimes) made in hosts. Expert Rev. Respir. Med. 1:7-16.
10. Leverentz, B., W. S. Conway, M. J. Camp, W. J. Janisiewicz, T. Abuladze, M. Yang, R. Saftner, and A. Sulakvelidze. 2003. Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin. Appl. Environ. Microbiol. 69:4519-4526.
11. Levin, B. R., and J. J. Bull. 1996. Phage therapy revisited: the population biology of a bacterial infection and its treatment with bacteriophage and antibiotics. Am. Nat. 147:881-898.
12. Levin, B. R., and J. J. Bull. 2004. Population and evolutionary dynamics of phage therapy. Nat. Rev. Microbiol. 2:166-173.
13. McVay, C. S., M. Velásquez, and J. A. Fralick. 2007. Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob. Agents Chemother. 51:1934-1938.
14. Merril, C. R., B. Biswas, R. Carlton, N. C. Jensen, G. J. Creed, S. Zullo, and S. Adhya. 1996. Long-circulating bacteriophage as antibacterial agents. Proc. Natl. Acad. Sci. USA 93:3188-3192.
15. Merril, C. R., D. Scholl, and S. L. Adhya. 2003. The prospect for bacteriophage therapy in Western medicine. Nat. Rev. Drug Discov. 2:489-497.
16. Middelboe, M. 2000. Bacterial growth rate and marine virus-host dynamics. Microb. Ecol. 40:114-124.
17. Mudgal, P., F. Breidt, Jr., S. R. Lubkin, and K. P. Sandeep. 2006. Quantifying the significance of phage attack on starter cultures: a mechanistic model for population dynamics of phage and their hosts isolated from fermenting sauerkraut. Appl. Environ. Microbiol. 72:3908-3915.
18. O'Flynn, G., A. Coffey, G. F. Fitzgerald, and R. P. Ross. 2006. The newly isolated lytic bacteriophages st104a and st104b are highly virulent against Salmonella enterica. J. Appl. Microbiol. 101:251-259.
19. O'Flynn, G., R. P. Ross, G. F. Fitzgerald, and A. Coffey. 2004. Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7. Appl. Environ. Microbiol. 70:3417-3424.
20. Paul, M., I. Benuri-Silbiger, K. Soares-Weiser, and L. Leibovici. 2004. β-Lactam monotherapy versus β-lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 328:668.
21. Payne, R. J. H., and V. A. A. Jansen. 2000. Phage therapy: the peculiar kinetics of self-replicating pharmaceuticals. Clin. Pharmacol. Ther. 68:225-230.
22. Payne, R. J. H., and V. A. A. Jansen. 2001. Understanding bacteriophage therapy as a density-dependent kinetic process. J. Theor. Biol. 208:37-48.
23. Payne, R. J. H., and V. A. A. Jansen. 2003. Pharmacokinetic principles of phage therapy. Clin. Pharmacokinet. 42:315-325.
24. Scott, A. E., A. R. Timms, P. L. Connerton, C. Loc Carrilo, K. Adzfa Radzum, and I. F. Connerton. 2007. Genome dynamics of Campylobacter jejuni in response to bacteriophage predation. PLoS Pathog. 3:e119.
25. Shen, Y., Y. Liu, Y. Zhang, J. Cripe, W. Conway, J. Meng, G. Hall, and A. A. Bhagwat. 2006. Isolation and characterization of Listeria monocytogenes isolates from ready-to-eat foods in Florida. Appl. Environ. Microbiol. 72:5073-5076.
26. Tanji, Y., T. Shimada, H. Fukudomi, K. Miyanaga, Y. Nakai, and H. Unno. 2005. Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice. J. Biosci. Bioeng. 100:280-287.
27. Tanji, Y., T. Shimada, K. Yoichi, K. Miyanaga, K. Hori, and H. Unno. 2004. Toward rational control of Escherichia coli O157:H7 by a phage cocktail. Appl. Microbiol. Biotechnol. 64:270-274.
28. Weld, R. J., C. Butts, and J. A. Heinemann. 2004. Models of phage growth and their applicability to phage therapy. J. Theor. Biol. 227:1-11.
29. Wiggins, B. A., and M. Alexander. 1985. Minimum bacterial density for bacteriophage replication: implications for significance of bacteriophages in natural ecosystems. Appl. Environ. Microbiol. 49:19-23.
30. Wood, S. N. 2001. Partially specified ecological models. Ecol. Monogr. 71:1-25.
31. Yoichi, M., M. Morita, K. Mizoguchi, C. R. Fischer, H. Unno, and Y. Tanji. 2004. The criterion for selecting effective phage for Escherichia coli O157:H7 control. Biochem. Eng. J. 19:221-227.
32. Zhao, X., and K. Drlica. 2001. Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. Clin. Infect. Dis. 33(Suppl. 3):S147-S156.
33. Zhao, X., and K. Drlica. 2002. Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window. J. Infect. Dis. 185:561-565.